Cargando…

Metabolomics and Lipidomics Screening Reveal Reprogrammed Signaling Pathways toward Cancer Development in Non-Alcoholic Steatohepatitis

With the rising incidence of hepatocellular carcinoma (HCC) from non-alcoholic steatohepatitis (NASH), identifying new metabolic readouts that function in metabolic pathway perpetuation is still a demand. The study aimed to compare the metabolic signature between NASH and NASH-HCC patients to explor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Eman A., El-Derany, Marwa O., Anwar, Ali Mostafa, Saied, Essa M., Magdeldin, Sameh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820351/ https://www.ncbi.nlm.nih.gov/pubmed/36613653 http://dx.doi.org/10.3390/ijms24010210

Ejemplares similares

Polymorphisms in Interleukin 13 Signaling and Interacting Genes Predict Advanced Fibrosis and Hepatocellular Carcinoma Development in Non-Alcoholic Steatohepatitis
por: El-Derany, Marwa O.
Publicado: (2020)

Differential Lipidomics, Metabolomics and Immunological Analysis of Alcoholic and Non-Alcoholic Steatohepatitis in Mice
por: Dorochow, Erika, et al.
Publicado: (2023)

Bone Marrow Mesenchymal Stem Cells and Their Derived Extracellular Vesicles Attenuate Non-Alcoholic Steatohepatitis-Induced Cardiotoxicity via Modulating Cardiac Mechanisms
por: El-Derany, Marwa O., et al.
Publicado: (2022)

A Novel Approach of SWATH-Based Metabolomics Analysis Using the Human Metabolome Database Spectral Library
por: Shikshaky, Hassan, et al.
Publicado: (2022)

Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis
por: Zhu, Qingfu, et al.
Publicado: (2022)

Human-stimulated oocyte extract induces genetic and mitochondrial reprogramming of mesenchymal stromal cells
por: El-Gammal, Zaynab, et al.
Publicado: (2020)

Metabolomic Predictors of Non-alcoholic Steatohepatitis and Advanced Fibrosis in Children
por: Kordy, Kattayoun, et al.
Publicado: (2021)

Proteomics and metabolomics analyses of Streptococcus agalactiae isolates from human and animal sources
por: Enany, Shymaa, et al.
Publicado: (2023)

Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro
por: Shatta, Mahmoud A., et al.
Publicado: (2022)

Toward deciphering proteomes of formalin-fixed paraffin-embedded (FFPE) tissues
por: Magdeldin, Sameh, et al.
Publicado: (2012)

Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases
por: Safaei, Akram, et al.
Publicado: (2016)

Lipidomics Revealed Alteration of the Sphingolipid Metabolism in the Liver of Nonalcoholic Steatohepatitis Mice Treated with Scoparone
por: Song, Qi, et al.
Publicado: (2022)

Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case study
por: El-Derany, Marwa O., et al.
Publicado: (2023)

Investigation into the antioxidant role of arginine in the treatment and the protection for intralipid-induced non-alcoholic steatohepatitis
por: Abu-Serie, Marwa M., et al.
Publicado: (2015)

parazitCUB: An R package to streamline the process of investigating the adaptations of parasites' codon usage bias
por: Anwar, Ali Mostafa, et al.
Publicado: (2023)

gtAI: an improved species-specific tRNA adaptation index using the genetic algorithm
por: Anwar, Ali Mostafa, et al.
Publicado: (2023)

Metabolomic Profiling to Identify Predictors of Response to Vitamin E for Non-Alcoholic Steatohepatitis (NASH)
por: Cheng, Jianfeng, et al.
Publicado: (2012)

Plasma Metabolomics and Machine Learning-Driven Novel Diagnostic Signature for Non-Alcoholic Steatohepatitis
por: Ji, Moongi, et al.
Publicado: (2022)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

Enantioselectivity Effects in Clinical Metabolomics and Lipidomics
por: Oliveira, Regina V., et al.
Publicado: (2021)

Bone marrow mesenchymal stem cells and their derived exosomes resolve doxorubicin-induced chemobrain: critical role of their miRNA cargo
por: El-Derany, Marwa O., et al.
Publicado: (2021)

Lipidomics Workflow for Analyzing Lipid Profiles Using Multiple Reaction Monitoring (MRM) in Liver Homogenate of Mice with Non-alcoholic Steatohepatitis (NASH)
por: Wee, Hai Ning, et al.
Publicado: (2023)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

Integrated Metabolomic and Lipidomic Analysis in the Placenta of Preeclampsia
por: Zhang, Lizi, et al.
Publicado: (2022)

Comparative Shotgun Proteomics Reveals the Characteristic Protein Signature of Osteosarcoma Subtypes
por: Alaa, Maram, et al.
Publicado: (2023)

Metabolomics study reveals the potential evidence of metabolic reprogramming towards the Warburg effect in precancerous lesions
por: Chen, Xun, et al.
Publicado: (2021)

Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr (-/-) mice
por: Garcia-Jaramillo, Manuel, et al.
Publicado: (2019)

Lipidomics and Redox Lipidomics Indicate Early Stage Alcohol‐Induced Liver Damage
por: Koelmel, Jeremy P., et al.
Publicado: (2021)

SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target
por: Yuan, Shuofeng, et al.
Publicado: (2019)

Liver Fibrogenesis in Non-Alcoholic Steatohepatitis
por: Bian, Zhaolian, et al.
Publicado: (2012)

Therapeutic approaches for non-alcoholic steatohepatitis
por: Van Gaal, Luc F., et al.
Publicado: (2021)

Perinatal Nutritional Reprogramming of the Epigenome Promotes Subsequent Development of Nonalcoholic Steatohepatitis
por: Gutierrez Sanchez, Luz Helena, et al.
Publicado: (2018)

Loss of SNORA73 reprograms cellular metabolism and protects against steatohepatitis
por: Sletten, Arthur C., et al.
Publicado: (2021)

Nano targeted Therapies Made of Lipids and Polymers have Promising Strategy for the Treatment of Lung Cancer
por: Essa, Marwa Labib, et al.
Publicado: (2020)

Inborn Errors of Metabolism in the Era of Untargeted Metabolomics and Lipidomics
por: Ismail, Israa T, et al.
Publicado: (2019)

Plasma metabolomic and lipidomic alterations associated with COVID-19
por: Wu, Di, et al.
Publicado: (2020)

Metabolomics and Lipidomics: Expanding the Molecular Landscape of Exercise Biology
por: Belhaj, Mehdi R., et al.
Publicado: (2021)

Integrated multiomics analysis to infer COVID-19 biological insights
por: Sameh, Mahmoud, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m9om4cljg6uoroa1i867a321vu